In receptor-driven systems, researchers can often connect ligand binding, receptor activation, downstream signaling, and biological outcome in a relatively linear sequence
Key Takeaways Topical peptides (especially GHK-Cu): Well-supported by human clinical studies for skincare
Doses available: 0.8mg 2.5mg 5.5mg 9.0mg 14.5mg 17.2mg Oral Weight Loss Medications (Non-GLP-1) Explore the range of NON-GLP-1 oral weight loss medications, thoughtfully selected to support appetite control, metabolism, and sustainable weight management
Intravesical capsaicin for treatment of detrusor hyperreflexia
Sikiric et al., 2020b) and complications (for review, see Sikiric et al., 2020b)
8 weeks: ~10 vials 12 weeks: ~19 vials 16 weeks: ~32 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe (1/day) 8 weeks: ~56 syringes 12 weeks: ~84 syringes 16 weeks: ~112 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per vial for reconstitution